Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 1179.30 -7.15 (-0.60%) | NSE 1175.50 -11.00 (-0.93%) | Trade | Add

BSE Live

Jan 16, 16:01

1179.30 -7.15 (-0.60%)

Volume

AVERAGE VOLUME

5-Day

70,898

10-Day

46,059

30-Day

65,929

608,516

NSE Live

Jan 16, 15:59

1175.50 -11.00 (-0.93%)

Volume

AVERAGE VOLUME

5-Day

1,801,044

10-Day

1,409,110

30-Day

1,348,916

2,214,792

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Dr Reddys Laboratories (in Rs. Cr.)	Mar 05	Mar 04
Per Share Ratios
Basic EPS (Rs.)	8.55	37.01
Diluted EPS (Rs.)	8.55	37.01
Cash EPS (Rs.)	21.32	46.38
Book Value [ExclRevalReserve]/Share (Rs.)	271.05	267.52
Book Value [InclRevalReserve]/Share (Rs.)	271.05	267.52
Dividend / Share(Rs.)	5.00	5.00
Revenue from Operations/Share (Rs.)	202.40	217.10
PBDIT/Share (Rs.)	18.37	49.09
PBIT/Share (Rs.)	6.29	39.72
PBT/Share (Rs.)	5.80	39.64
Net Profit/Share (Rs.)	8.55	37.01
Profitability Ratios
PBDIT Margin (%)	9.07	22.61
PBIT Margin (%)	3.10	18.29
PBT Margin (%)	2.86	18.26
Net Profit Margin (%)	4.22	17.04
Return on Networth / Equity (%)	3.15	13.83
Return on Capital Employed (%)	3.03	13.33
Return on Assets (%)	2.19	11.24
Total Debt/Equity (X)	0.13	0.03
Asset Turnover Ratio (%)	51.93	65.94
Liquidity Ratios
Current Ratio (X)	2.37	3.34
Quick Ratio (X)	2.00	2.68
Inventory Turnover Ratio (X)	5.10	6.44
Dividend Payout Ratio (NP) (%)	58.44	13.50
Dividend Payout Ratio (CP) (%)	23.45	10.77
Earnings Retention Ratio (%)	41.56	86.50
Cash Earnings Retention Ratio (%)	76.55	89.23
Valuation Ratios
Enterprise Value (Cr.)	5,037.03	7,102.71
EV/Net Operating Revenue (X)	3.25	4.28
EV/EBITDA (X)	35.83	18.91
MarketCap/Net Operating Revenue (X)	3.65	4.49
Retention Ratios (%)	41.55	86.49
Price/BV (X)	2.73	3.64
Price/Net Operating Revenue	3.65	4.49
Earnings Yield	0.01	0.04